Clinical Nanomedicine

Applications of nanotechnology for treatment, diagnosis, monitoring, and control of biological systems has recently been referred to as nanomedicine by the National Institutes of Health. Research into the rational delivery and targeting of pharmaceutical, therapeutic, and diagnostic agents is at the forefront of projects in nanomedicine. These involve the identification of precise targets (cells and receptors) related to specific clinical conditions and choice of the appropriate nanocarriers to achieve the required responses while minimizing the side effects. Mononuclear phagocytes, dendritic cells, endothelial cells, and cancers (tumor cells, as well as tumor neovasculature) are key targets. Online journals follow a systematic pattern with a particular style which is universally followed to avoid confusion. All the information should be unbiased, readily proven and can be challenged in any kind of situation. Each and every fact should be made clear by providing proper evidence thereby encouraging true scholar and safeguarding copyrights. Following such stringent rules and evaluation can be costly, so publishers charge from the users who access the information, but, it will obstruct research as young researchers can afford it. Alternatively, fees can be charged from the researcher who has made the research and it can be free to the user who is interested in research thus, increasing the popularity and reputation to scholar and enhancing knowledge to user.

• Share this page
• 
• 
• 
• 
• 
• 

Last date updated on April, 2024